Merck & Co., Inc.

This site was built with web standards. You are currently viewing the unformatted version of the website. Please update your browser in order to view the site.

Internet Explorer 5 or greater
Netscape 7
Mozilla
Opera 6 or greater

Skip navigation.

Personal Allergy Profile

It is always easier to begin a conversation with your doctor when you are prepared. By completing the following questionnaire, you can develop your own personalized discussion guide. Print this guide and take it with you the next time you meet with your doctor to talk about your allergy symptoms and treatment options.

Choose one:

My condition has been diagnosed as indoor/outdoor allergies.
My condition has not been diagnosed as indoor/outdoor allergies, but I wonder if I have them.
I am researching indoor/outdoor allergies for my child, a friend, or a relative.

SINGULAIR® (montelukast sodium) is a prescription medicine approved to help control asthma in adults and children as young as 12 months and to help relieve the symptoms of indoor and outdoor allergies (outdoor allergies in adults and children as young as 2 years, and indoor allergies in adults and children as young as 6 months).

IMPORTANT SAFETY INFORMATION

SINGULAIR should be taken once a day, as prescribed. SINGULAIR is available by prescription only.

Side effects are generally mild and vary by age, and may include headache, ear infection, sore throat, and upper respiratory infection. Side effects generally did not stop patients from taking SINGULAIR. SINGULAIR should not be taken by people who are sensitive to any of its ingredients.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

For additional safety information, please see Patient Product Information.

This site is intended only for residents of the United States, its territories, and Puerto Rico.
SINGULAIR and MerckServices are registered trademarks of Merck & Co., Inc. MerckSource is a trademark of Merck & Co., Inc.
20851228(2)-07/08-SNG